Bradford Hirsch

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

SignalPath LLC develops cloud-based software for the clinical research. Its solutions for research sites include financial management, site CTMS, enterprise performance, study startup. The company was founded by Bradford R. Hirsch and Kevin P. Monroe in 2014 and is headquartered in Raleigh, NC.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.

Highlander Partners LP (Highlander Partners) is a private equity firm founded in 2004 by Michael Robert Nicolais and Laurence E. Hirsch. The firm is headquartered in Dallas, Taxas.